Politicians slam tax-avoiding Pfizer-Allergan deal | WHAT REALLY HAPPENED

Politicians slam tax-avoiding Pfizer-Allergan deal

U.S. politicians condemned Pfizer Inc's deal with Allergan Plc as a tax dodge on Monday, bringing another round of hand-wringing in Washington over the corporate tax code, though legislative action before 2017 is unlikely.

Democrats heaped the most criticism on the New York-based drug maker, with Hillary Clinton accusing Pfizer of using legal loopholes to avoid its "fair share" of taxes in a deal that she said "will leave U.S. taxpayers holding the bag."

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA